8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Trafficking of synaptic vesicles is changed at the hypothalamus by exposure to an 835 MHz radiofrequency electromagnetic field

Bioeffects Seen

Kim JH, Huh YH, Kim HR · 2019

Share:

RF-EMF exposure altered synaptic vesicle trafficking and associated protein expression in hypothalamic presynaptic terminals, with potential implications for neurotransmitter release despite the absence of detectable phenotypic changes under these experimental conditions.

Plain English Summary

Summary written for general audiences

This study examined the effects of 835 MHz radiofrequency electromagnetic field exposure (4.0 W/kg SAR, 5 hours daily for 12 weeks) on synaptic vesicle trafficking in the hypothalamus of C57BL/6 mice. The researchers found significantly decreased numbers and sizes of synaptic vesicles, reduced density of docking and fusing vesicles in active zones, and decreased expression of synapsin I/II and synaptotagmin 1, though no significant changes in body temperature, weight, or behavioral measures were observed.

Why This Matters

Synaptic vesicle trafficking and synapsin proteins are critical for neurotransmitter release at neuronal synapses. The hypothalamus is a key brain region regulating neuroendocrine and autonomic functions, making it a relevant target for studying potential RF-EMF neurobiological effects.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Kim JH, Huh YH, Kim HR (2019). Trafficking of synaptic vesicles is changed at the hypothalamus by exposure to an 835 MHz radiofrequency electromagnetic field.
Show BibTeX
@article{kim_jh_huh_yh_kim_hr_ce3308,
  author = {Kim JH and Huh YH and Kim HR},
  title = {Trafficking of synaptic vesicles is changed at the hypothalamus by exposure to an 835 MHz radiofrequency electromagnetic field},
  year = {2019},
  doi = {10.4093/dmj.2018.0111},
  
}
DOI: 10.4093/dmj.2018.0111PubMed: 31411574

Quick Questions About This Study

People with persistent metabolic syndrome over 2 years had a 98% higher risk of developing diabetes during the 10-year follow-up period compared to those without metabolic syndrome, representing nearly double the baseline risk.
Yes, participants who resolved their metabolic syndrome showed significantly lower diabetes risk compared to those with persistent metabolic syndrome, though their risk remained 28% higher than people who never had metabolic syndrome.
Out of 7,317 participants aged 40-70 without diabetes at baseline, 1,099 people (15.0%) developed diabetes during the 10-year follow-up period in this Korean Genome Epidemiology Study.
Yes, the study found that diabetes risk gradually increased as the number of metabolic syndrome components increased over the 2-year monitoring period, showing a clear dose-response relationship between metabolic dysfunction and diabetes development.
The researchers studied 7,317 participants aged 40 to 70 years from the Korean Genome Epidemiology Study, following them from 2001 to 2011 to track metabolic syndrome changes and diabetes development.